Single peptide Vial strength 20 mg
Prostamax20 mg
Explore the format, calculations, and schedules reported for this compound.
Back to peptides
Get to know the compound
Prostamax, explained simply
A bioregulatory tetrapeptide associated with experimental research on prostate tissue.
Research area
Prostate research
How it works
Prostamax is a short bioregulatory peptide associated with research on prostate tissue.
Why it matters
It introduces a specific research line on short peptides and tissue function.
What has been observed
Possible interactions with gene expression are discussed in experimental models.
Effects and points to consider
Molecular hypotheses do not amount to a demonstrated benefit for prostate conditions.
01 / Vial strength 20 mg
Reported data
Doses and cycles are presented for information and education only; they are not prescriptions or medical advice.
Reported vial strength and reconstitution
| Vial contents | 20 mg Prostamax |
|---|---|
| Final volume | 2 mL |
| Concentration | 10 mg/mL |
| One U-100 unit | 100 mcg in 0.01 mL |
Standard / Gradual Approach (2 mL = 10 mg/mL)
| Phase / Week | Daily Dose (mcg / mg) | Units (per injection) (mL) |
|---|---|---|
| Weeks 1–2 | 500 mcg (0.5 mg) | 5 units (0.05 mL) |
| Weeks 3–4 | 750 mcg (0.75 mg) | 7.5 units (0.075 mL) |
| Weeks 5–8 | 1,000 mcg (1 mg) | 10 units (0.10 mL) |
| Weeks 9–12 (optional extension) | 1,000 mcg (1 mg) | 10 units (0.10 mL) |
Supplies needed
View on Amazon
Sterile alcohol swabs
SOURCES
Scientific references
Links reported by the source and selected by type. Their presence does not validate this page’s dosage data.